Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study

OBJECTIVES: To compare the effectiveness of rituximab versus an alternative tumour necrosis factor (TNF) inhibitor (TNFi) in patients with rheumatoid arthritis (RA) with an inadequate response to one previous TNFi. METHODS: SWITCH-RA was a prospective, global, observational, real-life study. Patient...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Rheum Dis
Autors principals: Emery, P, Gottenberg, J E, Rubbert-Roth, A, Sarzi-Puttini, P, Choquette, D, Taboada, V M Martínez, Barile-Fabris, L, Moots, R J, Ostor, A, Andrianakos, A, Gemmen, E, Mpofu, C, Chung, C, Gylvin, L Hinsch, Finckh, A
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2015
Matèries:
Clinical and Epidemiological Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4431330/
https://ncbi.nlm.nih.gov/pubmed/24442884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2013-203993
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars